S. 2282: Stem Cell Therapeutic and Research Reauthorization Act of 2015

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.
Introduced:

Nov 16, 2015

Status:

Referred to Committee on Nov 16, 2015

This bill was assigned to a congressional committee on November 16, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.

Sponsor:

Orrin Hatch

Senior Senator from Utah

Republican

Text:

Read Text »
Last Updated: Nov 16, 2015
Length: 5 pages

Prognosis:

12% chance of being enacted (details)

See Instead:

H.R. 2820 (same title)
Enacted — Signed by the President — Dec 18, 2015

About the bill

Full Title

A bill to amend the Public Health Service Act to reauthorize the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory, and for other purposes.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Nov 16, 2015
 
Introduced

This is the first step in the legislative process.

 
Reported by Committee

 
Passed Senate

 
Passed House

 
Signed by the President

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: